Preference for Rituximab Subcutaneous (Sc) and Intravenous (Iv) Among Patients With Cd20+ Non-Hodgkin's Lymphoma (Nhl) Completing the Rasq Measure In Randomized Phase Iii Studies Prefmab and Mabcute.
作者信息
Rule S, Briones J, Smith R, Theodore Oklota C, Ngoh C A, Osborne S, Capochiani E, Rummel M
机构信息
Derriford Hospital, Plymouth, UK.
Santa Creu i Sant Pau Hospital, Barcelona, Spain.
出版信息
Value Health. 2014 Nov;17(7):A537. doi: 10.1016/j.jval.2014.08.1719. Epub 2014 Oct 26.
PMID:27201719
Abstract
摘要
Zotero 插件